WGU D027 Study Guide (Latest 2023 – 2024)
Questions With Verified Answers
Autosomal ,aDominant ,a- ,aAnswer ,a- ,a ,a ,a1 ,aparent ,ahas, ,a50% ,achange ,aof ,achild ,ahaving
Autosomal ,aRecessive ,a- ,aAnswer ,a- ,a ,a ,aBoth ,aparents ,aare ,acarriers, ,a25% ,achange ,aof ,achi
ld ,ahaving, ,a50% ,achance ,achild ,ais ,aa ,acarrier.
Cystic ,aFibrosis ,a- ,aAnswer ,a- ,a ,a ,aaffects ,apancreas ,acausing ,asecretions ,ain ,alungs
21st ,aTrisomy ,a- ,aAnswer ,a- ,a ,a ,aDown ,aSyndrome
Klinefelter ,aSyndrome ,a(XXY) ,a- ,aAnswer ,a- ,a ,a ,amale ,ahas ,aextra ,aX, ,afemale ,alike ,aqualities
Turner ,aSyndrome ,a- ,aAnswer ,a- ,a ,a ,aMissing ,aX ,ain ,afemales
Alpha ,aThalassemia ,a- ,aAnswer ,a- ,a ,a ,ainherited ,ablood ,adisorder; ,amild ,ato ,asevere ,aanemia
Beta ,aThallasemia ,a- ,aAnswer ,a- ,a ,a ,alow ,ahemoglobin; ,acontraindicated ,amedication ,aferrou
s ,asulfate
Prevalence ,aRisk ,a- ,aAnswer ,a- ,a ,a ,aproportion ,aof ,athe ,apopulation ,aaffected ,aat ,aa ,acertain ,at
ime
Incidence ,arate ,a- ,aAnswer ,a- ,a ,a ,anumber ,aof ,anew ,acases ,adivided ,aby ,apopulation
Innate ,aimmunity ,a- ,aAnswer ,a- ,a ,a ,ainflammation; ,aincreased ,avascular ,apermeability
B&T ,alymphocytes ,a- ,aAnswer ,a- ,a ,a ,aimmune ,aresponse
primary ,amalignant ,atumor ,a- ,aAnswer ,a- ,a ,a ,alack ,aof ,aorganization ,aof ,acells
glucocorticoids ,a- ,aAnswer ,a- ,a ,a ,aused ,ain ,acombination ,awith ,aother ,aagent ,ato ,atreat ,alymph
oid ,atissue ,a(leukemia). ,aglucocorticoids ,aare ,adirectly ,atoxic ,ato ,alymphoid ,atissues.
Selective ,aestrogen ,areceptor ,amodulators ,a(SERM) ,a- ,aAnswer ,a- ,a ,a ,afor ,ahormone ,arecept
or ,apositive ,aand ,aadvanced ,abreast ,acancer. ,a(Tamoxifin ,areduces ,arisk ,aand ,arecurrence ,a
risk)
, Heart ,afailure ,a- ,aAnswer ,a- ,a ,a ,aimpairment ,aof ,athe ,aventricle ,ato ,afill ,awith ,aor ,aeject ,ablood; ,a
heart ,acannot ,ameet ,ametabolic ,aneed ,aof ,athe ,abody.
CHF ,a- ,aAnswer ,a- ,a ,a ,aheart ,acannot ,akeep ,aup ,awith ,ametabolic ,aneeds; ,avolume ,aoverload ,
ain ,apulmonary ,aarea
Left ,aVentricular ,aDysfunction ,a- ,aAnswer ,a- ,a ,a ,areduced ,aejection ,afraction; ,aventricle ,ahavi
ng ,aissue ,aejecting ,ablood.
normal ,aejection ,afraction ,a- ,aAnswer ,a- ,a ,a ,a55 ,a- ,a60 ,a
% ,a(blood ,apumped ,aout ,awith ,aeach ,aheartbeat)
Ejection ,afraction ,aof ,a50% ,a- ,areduced ,aor ,apreserved? ,a- ,aAnswer ,a- ,a ,a ,apreserved
Diastolic ,aCHF ,a- ,aAnswer ,a- ,a ,a ,apreserved ,aejection ,afraction, ,aproblem ,ais ,awith ,afilling
Systolic ,aCHF ,a- ,aAnswer ,a- ,a ,a ,areduced ,aejection ,afraction, ,aproblem ,ais ,awith ,aejecting
Left ,asided ,aCHF ,a- ,aAnswer ,a- ,a ,a ,apulmonary ,a(JVD, ,afluid ,avolume ,aoverload, ,arails, ,aS-
3 ,amurmurs) ,a** ,a#1 ,acause ,aof ,aRight ,asided ,aCHF
BNP ,a- ,aAnswer ,a- ,a ,a ,agold ,astandard ,alab ,atest ,ato ,adiagnose ,aCHF
Echocardiogram ,a- ,aAnswer ,a- ,a ,a ,aDiagnostic ,atool, ,aevaluates ,aheart ,astructure ,aand ,afunct
ion
At ,aRisk ,afor ,aHF ,a- ,aStage ,aA ,a- ,aAnswer ,a- ,a ,a ,ano ,astructural ,aheart ,adisease ,aor ,asymptoms
,aof ,aheart ,afailure
Stage ,aA ,aHF ,aco-
morbidities ,a- ,aAnswer ,a- ,a ,a ,ahtn, ,aatherosclerotic ,adisease, ,adiabetes, ,ametabolic ,asyndro
me, ,apatients ,ausing ,acardiotoxins ,awith ,afamily ,ahistory
Therapy ,agoals ,aof ,astage ,aA ,aHF ,a- ,aAnswer ,a- ,a ,a ,atreat ,ahtn, ,aencourage ,asmoking ,acessati
on, ,aencourage ,aregular ,aexercise, ,atreat ,alipid ,adisorders, ,adiscourage ,aalcohol ,
aintake/drug ,ause, ,acontrol ,ametabolic ,asyndrome
Meds: ,aACEI ,aor ,aAngiotensin ,aII ,aRB ,afor ,avascular ,adisease ,aor ,adiabetes ,a(avapro, ,alosart
an, ,abenicar, ,adiovan, ,aetc)
At ,aRisk ,afor ,aHF ,a- ,aStage ,aB ,a- ,aAnswer ,a- ,a ,a ,astructural ,aheart ,adisease ,abut ,ano ,asymptom
s ,aof ,aheart ,afailure
Stage ,aB ,aHF ,aco-
morbidities ,a- ,aAnswer ,a- ,a ,a ,aprevious ,aMI, ,aLV ,aremodeling ,awith ,aLV ,ahypertrophy ,aand ,alo
w ,aEF, ,aasymptomatic ,avalvular ,adisease
Questions With Verified Answers
Autosomal ,aDominant ,a- ,aAnswer ,a- ,a ,a ,a1 ,aparent ,ahas, ,a50% ,achange ,aof ,achild ,ahaving
Autosomal ,aRecessive ,a- ,aAnswer ,a- ,a ,a ,aBoth ,aparents ,aare ,acarriers, ,a25% ,achange ,aof ,achi
ld ,ahaving, ,a50% ,achance ,achild ,ais ,aa ,acarrier.
Cystic ,aFibrosis ,a- ,aAnswer ,a- ,a ,a ,aaffects ,apancreas ,acausing ,asecretions ,ain ,alungs
21st ,aTrisomy ,a- ,aAnswer ,a- ,a ,a ,aDown ,aSyndrome
Klinefelter ,aSyndrome ,a(XXY) ,a- ,aAnswer ,a- ,a ,a ,amale ,ahas ,aextra ,aX, ,afemale ,alike ,aqualities
Turner ,aSyndrome ,a- ,aAnswer ,a- ,a ,a ,aMissing ,aX ,ain ,afemales
Alpha ,aThalassemia ,a- ,aAnswer ,a- ,a ,a ,ainherited ,ablood ,adisorder; ,amild ,ato ,asevere ,aanemia
Beta ,aThallasemia ,a- ,aAnswer ,a- ,a ,a ,alow ,ahemoglobin; ,acontraindicated ,amedication ,aferrou
s ,asulfate
Prevalence ,aRisk ,a- ,aAnswer ,a- ,a ,a ,aproportion ,aof ,athe ,apopulation ,aaffected ,aat ,aa ,acertain ,at
ime
Incidence ,arate ,a- ,aAnswer ,a- ,a ,a ,anumber ,aof ,anew ,acases ,adivided ,aby ,apopulation
Innate ,aimmunity ,a- ,aAnswer ,a- ,a ,a ,ainflammation; ,aincreased ,avascular ,apermeability
B&T ,alymphocytes ,a- ,aAnswer ,a- ,a ,a ,aimmune ,aresponse
primary ,amalignant ,atumor ,a- ,aAnswer ,a- ,a ,a ,alack ,aof ,aorganization ,aof ,acells
glucocorticoids ,a- ,aAnswer ,a- ,a ,a ,aused ,ain ,acombination ,awith ,aother ,aagent ,ato ,atreat ,alymph
oid ,atissue ,a(leukemia). ,aglucocorticoids ,aare ,adirectly ,atoxic ,ato ,alymphoid ,atissues.
Selective ,aestrogen ,areceptor ,amodulators ,a(SERM) ,a- ,aAnswer ,a- ,a ,a ,afor ,ahormone ,arecept
or ,apositive ,aand ,aadvanced ,abreast ,acancer. ,a(Tamoxifin ,areduces ,arisk ,aand ,arecurrence ,a
risk)
, Heart ,afailure ,a- ,aAnswer ,a- ,a ,a ,aimpairment ,aof ,athe ,aventricle ,ato ,afill ,awith ,aor ,aeject ,ablood; ,a
heart ,acannot ,ameet ,ametabolic ,aneed ,aof ,athe ,abody.
CHF ,a- ,aAnswer ,a- ,a ,a ,aheart ,acannot ,akeep ,aup ,awith ,ametabolic ,aneeds; ,avolume ,aoverload ,
ain ,apulmonary ,aarea
Left ,aVentricular ,aDysfunction ,a- ,aAnswer ,a- ,a ,a ,areduced ,aejection ,afraction; ,aventricle ,ahavi
ng ,aissue ,aejecting ,ablood.
normal ,aejection ,afraction ,a- ,aAnswer ,a- ,a ,a ,a55 ,a- ,a60 ,a
% ,a(blood ,apumped ,aout ,awith ,aeach ,aheartbeat)
Ejection ,afraction ,aof ,a50% ,a- ,areduced ,aor ,apreserved? ,a- ,aAnswer ,a- ,a ,a ,apreserved
Diastolic ,aCHF ,a- ,aAnswer ,a- ,a ,a ,apreserved ,aejection ,afraction, ,aproblem ,ais ,awith ,afilling
Systolic ,aCHF ,a- ,aAnswer ,a- ,a ,a ,areduced ,aejection ,afraction, ,aproblem ,ais ,awith ,aejecting
Left ,asided ,aCHF ,a- ,aAnswer ,a- ,a ,a ,apulmonary ,a(JVD, ,afluid ,avolume ,aoverload, ,arails, ,aS-
3 ,amurmurs) ,a** ,a#1 ,acause ,aof ,aRight ,asided ,aCHF
BNP ,a- ,aAnswer ,a- ,a ,a ,agold ,astandard ,alab ,atest ,ato ,adiagnose ,aCHF
Echocardiogram ,a- ,aAnswer ,a- ,a ,a ,aDiagnostic ,atool, ,aevaluates ,aheart ,astructure ,aand ,afunct
ion
At ,aRisk ,afor ,aHF ,a- ,aStage ,aA ,a- ,aAnswer ,a- ,a ,a ,ano ,astructural ,aheart ,adisease ,aor ,asymptoms
,aof ,aheart ,afailure
Stage ,aA ,aHF ,aco-
morbidities ,a- ,aAnswer ,a- ,a ,a ,ahtn, ,aatherosclerotic ,adisease, ,adiabetes, ,ametabolic ,asyndro
me, ,apatients ,ausing ,acardiotoxins ,awith ,afamily ,ahistory
Therapy ,agoals ,aof ,astage ,aA ,aHF ,a- ,aAnswer ,a- ,a ,a ,atreat ,ahtn, ,aencourage ,asmoking ,acessati
on, ,aencourage ,aregular ,aexercise, ,atreat ,alipid ,adisorders, ,adiscourage ,aalcohol ,
aintake/drug ,ause, ,acontrol ,ametabolic ,asyndrome
Meds: ,aACEI ,aor ,aAngiotensin ,aII ,aRB ,afor ,avascular ,adisease ,aor ,adiabetes ,a(avapro, ,alosart
an, ,abenicar, ,adiovan, ,aetc)
At ,aRisk ,afor ,aHF ,a- ,aStage ,aB ,a- ,aAnswer ,a- ,a ,a ,astructural ,aheart ,adisease ,abut ,ano ,asymptom
s ,aof ,aheart ,afailure
Stage ,aB ,aHF ,aco-
morbidities ,a- ,aAnswer ,a- ,a ,a ,aprevious ,aMI, ,aLV ,aremodeling ,awith ,aLV ,ahypertrophy ,aand ,alo
w ,aEF, ,aasymptomatic ,avalvular ,adisease
